Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease.
about
A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1Rho/Rock cross-talks with transforming growth factor-β/Smad pathway participates in lung fibroblast-myofibroblast differentiation.Constitutive activation of transforming growth factor Beta receptor 1 in the mouse uterus impairs uterine morphology and functionPharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammationInhibitory Effect of Delphinidin on Extracellular Matrix Production via the MAPK/NF-κB Pathway in Nasal Polyp-Derived Fibroblasts.Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.Cross regulation between hypoxia-inducible transcription factor-1α (HIF-1α) and transforming growth factor (TGF)-ß1 mediates nickel oxide nanoparticles (NiONPs)-induced pulmonary fibrosisIncreased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.Mechanisms of Lung Fibrosis Resolution.A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections.BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.Type 2 immunity in tissue repair and fibrosis.Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition.NF-κB Mediates Mesenchymal Transition, Remodeling, and Pulmonary Fibrosis in Response to Chronic Inflammation by Viral RNA Patterns.Constrictive Bronchiolitis in Cystic Fibrosis Adolescents with Refractory Pulmonary Decline.Periostin Deficiency Causes Severe and Lethal Lung Injury in Mice With Bleomycin Administration.Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition.Maresin 1 inhibits transforming growth factor-β1-induced proliferation, migration and differentiation in human lung fibroblastsmicroRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia.TGFβ as a therapeutic target in cystic fibrosis.Constrictive Bronchiolitis: A Distinct Phenotype of Cystic Fibrosis Lung Disease?Airway remodeling is reversed by aerobic training in a murine model of chronic asthma.Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.Abnormal expression of fibrosis markers, estrogen receptor α and stromal derived factor‑1/chemokine (C‑X‑C motif) receptor‑4 axis in intrauterine adhesions.
P2860
Q28543256-012041C0-5B6B-4BAC-891B-0625029E7ADCQ34265555-D9A517E5-AF74-4458-BC01-A0BC70EDC734Q34453805-878AD759-4942-4CDF-B786-93DF8589C9CEQ35073075-E86B5FB2-9939-49C6-A739-AB6CDC2DCF74Q35420612-B17021F5-761A-4676-91A4-4A8F2DF37A2BQ36306603-C5B7B7E5-4AF3-4510-824A-891F56448F78Q36420270-43EBE5B2-DBC9-40BC-8B0D-D869FB4894FFQ36811246-077BA737-265B-4F35-8FF4-DC676347E9C9Q36885732-EB9F420C-2E90-4996-8669-CFCEAA3296DDQ37591319-77EB43C5-862B-4D85-828B-DB11E43B9BDDQ38522938-1F84CDD9-052D-4056-85C7-985F7D52A913Q39236663-06D2A718-1A7C-4D2A-9FD7-E20687074D71Q40074887-1539B0C9-0AF1-4519-886D-912447180DA0Q40172758-943D3969-1BF4-434D-AF5E-B1584A8EE553Q40426338-BE6B0B5E-4FC6-4D57-BD54-26E48E2EC402Q40560942-C033B6E0-2EF9-4E15-ADA4-D9BC80FBEC71Q42013680-C4A5E640-355B-493E-9B9B-5D143D15E4CFQ42324062-18AC791C-B56A-46CD-B395-0A797674CCCCQ42835940-810E75AE-3E9B-4C7F-9951-0ADB7BA8FCA2Q47302859-80E1C1A7-062E-43A6-93E4-623BFF4F218DQ47822059-22D98736-EFC1-4D0A-99CA-48EEADFD2DBBQ48025133-97E79131-124D-4520-9FE2-A59F7E48BD26Q51701884-FBF43D20-D35A-4E75-BF80-A2B455BECB26Q52633077-A045C6C6-5811-4012-95BD-E3CDEFA3ECB0Q52641323-271D8F93-2E0B-4965-A114-CEC54F7EC665
P2860
Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@ast
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@en
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@nl
type
label
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@ast
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@en
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@nl
prefLabel
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@ast
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@en
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@nl
P2093
P2860
P1433
P1476
Myofibroblast differentiation ...... cystic fibrosis lung disease.
@en
P2093
Dezhi Wang
Eric J Sorscher
J P Clancy
James S Hagood
Mark MacEwen
William T Harris
P2860
P304
P356
10.1371/JOURNAL.PONE.0070196
P407
P577
2013-08-12T00:00:00Z